Progress announcement regarding providing guarantees for subsidiary.
Yunnan Jianzhijia Health-Chain investor relations activity record (April-June 2024)
Announcement on the Results of Stock Repurchase Implementation and Share Changes.
Announcement of expected semi-annual performance decrease in 2024.
Announcement Regarding Additional Pledging of Shares by the Actual Controller of the Company
Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Announcement Regarding the Reduction of Restricted Stocks Subject to Buyback and Cancellation, Decrease of Registered Capital and Notice to Creditors.
Announcement of the results of the restricted stock incentive plan granted in 2024.
Legal Opinion of Deheng (Kunming) Law Firm on the First Extraordinary General Meeting of Shareholders of Yunnan Jianzhijia Health-Chain Pharmaceutical Retail Group Co., Ltd. in 2024.
Announcement of the resolution of the first extraordinary shareholders meeting in 2024.
Announcement on the Progress of Repurchasing Shares through the Centralized Bidding Trading Method.
Announcement of the resolution of the first holder meeting of the 2024 employee shareholding plan.
Material for the first interim shareholder meeting in 2024.
Announcement Regarding the Company's First Stock Repurchase through Centralized Competitive Trading Method.
Report on Repurchasing Shares by means of Centralized Bidding Trading
Progress announcement regarding providing guarantees for subsidiary.
Announcement regarding the top ten shareholders and the top ten shareholders with unlimited sales conditions, on the matter of repurchasing stocks.
Announcement of Resolutions of the Fifth Meeting of the Sixth Board of Directors.
Announcement on the plan of repurchasing shares through centralized bidding trade method.
Legal opinion of Deheng (Kunming) Law Firm on the achievement of the first release of restrictions on the grant of the third phase of the restricted stock incentive plan of Yunnan Jianzhijia Health-Chain Pharmaceutical Chain Group Co., Ltd. in 2021.
No Data